Press Releases

Health News Posted on Saturday, May 30, 2015

Premium Press Releases »

Europes Main Computational Biology Conference Comes to Turku, Finland

Discoveries made when biology meets computational sciences are revolutionising the landscape of life sciences and healthcare. Computational biology and bioinformatics are driving this transformation helping researchers analyse vast amounts of ...

Read More

Press Releases »

GenomeDx's Decipher Prostate Cancer Test is Significant Predictor of Metastasis in Patients With Detectable PSA Following Treatment with Radiation after Prostate Surgery, According to Study Presented at ASCO 2015 Annual Meeting

Decipher test results show potential utility in determining benefit of hormone therapy and timing of salvage radiation therapy CHICAGO , May 30, 2015 /PRNewswire/ -- GenomeDx Biosciences today announced that data presented at the 2015 ...

Read More

OncoGenex Announces Data from the Phase 3 SYNERGY Trial Showing a Survival Benefit with Custirsen in Patients with Poor Prognosis

Significant reduction in risk of death observed in those patients with most common risk factors that drive poor outcomes in prostate cancer BOTHELL, Wash. and VANCOUVER, British Columbia , May 30, 2015 /PRNewswire/ -- OncoGenex ...

Read More

Initial Data from Ongoing Expansion Study of MGCD265 Show Preliminary Evidence of Clinical Efficacy in Heavily Pretreated Non-Small Cell Lung Cancer (NSCLC) Patients with MET Gene Alterations

- The First Three Patients Selected for MET Gene Alterations in MGCD265 Dose Expansion Cohort Show Clear Evidence of Tumor Regression CHICAGO , May 30, 2015 /PRNewswire/ -- Mirati Therapeutics, Inc. ("Mirati") (NASDAQ: MRTX) today presented ...

Read More

Caris Life Sciences Paired Tumor Data Identifies Key Driver Mutations and Confirms Tumor Heterogeneity in High-Grade Glioma Samples

Paired Tumor Research in Glioma, Breast Cancer and Epithelial Ovarian Carcinoma Guides Clinical Application of Comprehensive Tumor Profiling IRVING, Texas , May 30, 2015 /PRNewswire/ --   Caris Life Sciences® today announced the presentation ...

Read More

Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features

ASCO Presentations Highlight Therapeutic Implications of Similar Genetic Landscape for Brain Metastases in NSCLC, Breast Cancer and Melanoma, as well as Similarities and Differences Between Endometrial, Renal and Ovarian Cancers IRVING, ...

Read More

Ibrutinib (IMBRUVICA®) HELIOS Interim Analysis Study Data Show Significant Reductions in Risk of Progression or Death in Patients with Previously-Treated Chronic Lymphocytic Leukemia

Phase 3 data (abstract LBA7005) featured in the official press program of the 51st annual meeting of the American Society of Clinical Oncology CHICAGO and RARITAN, N.J. , May 30, 2015 /PRNewswire/ -- Data from the Phase 3 CLL3001 (HELIOS) ...

Read More

Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients

Results from the Phase 2 MMY2002 trial (Abstract LBA8512) featured in the official press program of the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) CHICAGO and RARITAN, N.J. , May 30, 2015 /PRNewswire/ -- Data ...

Read More

Phase III HELIOS Study Results Show Ibrutinib (IMBRUVICA®) Combination Therapy Significantly Increased Progression-Free Survival in Previously-Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Patients

Data featured in today's official press program at American Society of Clinical Oncology Annual Meeting CHICAGO , May 30, 2015 /PRNewswire/ -- Today, Pharmacyclics LLC announced the results of the Phase III HELIOS trial (CLL3001), which ...

Read More

Creating an Effective Pharmaceutical Medical Affairs Group with Global Capabilities

CHAPEL HILL, N.C. , May 29, 2015 /PRNewswire/ -- The changing healthcare landscape has pushed the medical affairs function into roles involving clinical development, regulatory compliance and market education. As its responsibilities have ...

Read More

BGB324 and BGB10C9 Show Promise in Models of Pancreatic Cancer

BERGEN, Norway , May 29, 2015 /PRNewswire/ -- BerGenBio AS ("BerGenBio" or the "Company"), an oncology biopharmaceutical company, today announces that an abstract on the latest data on BGB324, the Company's first-in-class, selective small ...

Read More

Government of Canada improves access to gluten-free foods

New category of "gluten-free" claims allowed for specially produced oats OTTAWA , May 29, 2015 /CNW/ - To mark Celiac Awareness Month, the Honourable Rona Ambrose, Minister of Health today announced changes that will result in more safe food ...

Read More

Delayed Diagnosis of Lyme Disease Has Devastating Effect on Patients

According to a nationwide survey by LymeDisease.org, only 7% of chronic Lyme patients are diagnosed and treated within critical thirty-day window essential to cure. More than half wait two years or more for correct diagnosis. SAN FRANCISCO , ...

Read More

Anpac Bio-Medical Introduces 'Game Changing' Cancer Screening Tech at American Society of Clinical Oncology Meeting - Chicago 5/29 - 6/2

Anpac Discloses 'Breakthrough' Early Cancer Detection 'Blood Biopsy' SACRAMENTO, Calif. , May 29, 2015 /PRNewswire/ -- Anpac Bio-Medical Science Co., Ltd., Chief Executive Officer and Scientist Dr. Chris Yu and the Anpac research team are ...

Read More
More Press Releases

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.